Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Urologist Practice Structure and Spending for Prostate Cancer Care.

Modi PK, Herrel LA, Kaufman SR, Yan P, Borza T, Skolarus TA, Schroeck FR, Hollenbeck BK, Shahinian VB.

Urology. 2019 Apr 25. pii: S0090-4295(19)30372-3. doi: 10.1016/j.urology.2019.03.029. [Epub ahead of print]

PMID:
31029672
2.

Urologists' estimations of the cost of commonly used disposable devices.

Farber NJ, Chuchvara N, Modi PK, Sterling J, Elsamra SE.

Can J Urol. 2019 Feb;26(1):9660-9663.

PMID:
30797249
3.

Editorial Comment.

Modi PK.

Urology. 2019 Feb;124:228. doi: 10.1016/j.urology.2018.10.026. No abstract available.

PMID:
30784713
4.

EDITORIAL COMMENT.

Modi PK.

Urology. 2019 Feb;124:105-106. doi: 10.1016/j.urology.2018.07.042. No abstract available.

PMID:
30784706
5.

Impact of Medicare Office Visit Payment Reform on Urologic Practices.

Modi PK, Kaufman SR, Caram MV, Ellimoottil C, Shahinian VB, Hollenbeck BK.

Urology. 2019 Apr;126:83-88. doi: 10.1016/j.urology.2019.01.013. Epub 2019 Jan 22.

PMID:
30682462
6.

Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures.

Modi PK, Kaufman SR, Borza T, Oliphant BW, Ryan AM, Miller DC, Shahinian VB, Ellimoottil C, Hollenbeck BK.

Surg Innov. 2019 Apr;26(2):227-233. doi: 10.1177/1553350618816594. Epub 2018 Nov 30.

PMID:
30497340
7.

Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.

Farber NJ, Rivera-Núñez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, Weiss RE, Kim IY, Elsamra SE, Jang TL, Singer EA.

Urol Oncol. 2019 Jan;37(1):26-32. doi: 10.1016/j.urolonc.2018.10.004. Epub 2018 Nov 13.

PMID:
30446458
8.

Searching for the value of accountable care organizations in cancer care.

Modi PK, Hollenbeck BK, Borza T.

Cancer. 2018 Nov 15;124(22):4287-4289. doi: 10.1002/cncr.31698. Epub 2018 Nov 12. No abstract available.

PMID:
30419155
9.

Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.

Modi PK, Hollenbeck BK, Oerline M, Weizer AZ, Montgomery JS, Kaffenberger SD, Ryan AM, Ellimoottil C.

Urology. 2019 Mar;125:86-91. doi: 10.1016/j.urology.2018.10.022. Epub 2018 Oct 23.

PMID:
30366043
10.

The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network.

Sahu A, Gopalakrishnan L, Gaur N, Chatterjee O, Mol P, Modi PK, Dagamajalu S, Advani J, Jain S, Keshava Prasad TS.

J Cell Commun Signal. 2018 Dec;12(4):731-735. doi: 10.1007/s12079-018-0482-2. Epub 2018 Jul 24.

11.

Tradeoffs in Refining the Diagnosis of Prostate Cancer.

Modi PK, Morgan TM.

Eur Urol. 2018 Dec;74(6):729-730. doi: 10.1016/j.eururo.2018.07.008. Epub 2018 Jul 19. No abstract available.

PMID:
30031570
12.

National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.

Modi PK, Kaufman SR, Qi J, Lane BR, Cher ML, Miller DC, Hollenbeck BK, Shahinian VB, Dupree JM.

Urology. 2018 Oct;120:96-102. doi: 10.1016/j.urology.2018.06.037. Epub 2018 Jul 7.

PMID:
29990573
13.

Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.

Modi PK, Kaufman SR, Borza T, Yan P, Miller DC, Skolarus TA, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK.

Cancer. 2018 Aug;124(16):3364-3371. doi: 10.1002/cncr.31573. Epub 2018 Jun 15.

PMID:
29905943
14.

Engaging telehealth to drive value-based urology.

Modi PK, Portney D, Hollenbeck BK, Ellimoottil C.

Curr Opin Urol. 2018 Jul;28(4):342-347. doi: 10.1097/MOU.0000000000000508.

PMID:
29697472
15.

The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications.

Modi PK, Wang Y, Kirk PS, Dupree JM, Singer EA, Chang SL.

Urology. 2018 Jul;117:50-56. doi: 10.1016/j.urology.2018.04.008. Epub 2018 Apr 20.

PMID:
29680480
16.

Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013.

Faiena I, Tabakin A, Leow J, Patel N, Modi PK, Salmasi AH, Chung BI, Chang SL, Singer EA.

Can J Urol. 2017 Oct;24(5):8990-8997.

PMID:
28971785
17.

Pediatric hospitalizations for upper urinary tract calculi: Epidemiological and treatment trends in the United States, 2001-2014.

Modi PK, Kwon YS, Davis RB, Elsamra SE, Dombrovskiy V, Olweny EO.

J Pediatr Urol. 2018 Feb;14(1):13.e1-13.e6. doi: 10.1016/j.jpurol.2017.09.001. Epub 2017 Sep 7.

PMID:
28966022
18.

Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.

Modi PK, Farber NJ, Zavaski ME, Jang TL, Singer EA, Chang SL.

Urol Pract. 2017 Jul;4(4):342-347.

19.

Renal cell carcinoma: the search for a reliable biomarker.

Farber NJ, Kim CJ, Modi PK, Hon JD, Sadimin ET, Singer EA.

Transl Cancer Res. 2017 Jun;6(3):620-632. doi: 10.21037/tcr.2017.05.19.

20.

Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.

Modi PK, Bock M, Kim S, Singer EA, Parikh RR.

Clin Genitourin Cancer. 2017 Dec;15(6):e1001-e1006. doi: 10.1016/j.clgc.2017.05.013. Epub 2017 May 10.

Supplemental Content

Support Center